NFKB1 and type 2 diabetes mellitus: Having studied the specified intermediates NF-κB, IκBα, TNFα, IL-6, JNK, AMPK and ACC, it is noteworthy that the study does not provide a complete picture of the connection between signaling pathways promoting inflammation and those regulating insulin sensitivity in the skeletal muscle tissue of type 2 diabetic patients.